Top Michigan Biotech Startups (35)
Helix is a value-based, state-of-the-art clinical laboratory on a mission to elevate the lab space through compliance, high ethics, innovation and a best in class client experience. Helix incorporates the latest technology and methods to provide comprehensive diagnostics including toxicology testing, pathogen detection, blood testing and Pharmacogenomics (PGx) testing. We also provide drive up COVID-19 testing.
Genetics Squared is a biotechnology company that develops solutions for personalized medicines.
LynxDx offers technologies that enable early cancer detection and improvement of patient care.
Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted
We are a preclinical stage AI drug discovery company with a mission to eliminate age-related diseases We use AI to build clinically relevant disease phenotypes in real-world human data and identify diseases with shared biology. Then WES-enabled genetic study on these phenotypes allows us to discover novel targets applicable to several indications at once.
Strata Oncology is a precision oncology company dedicated to transforming cancer care.
Allozymes is a leading deep technology company that applies its proprietary microfluidics technology to develop custom-designed enzymes for cleaner and sustainable manufacturing of complex natural products. Allozymes’ interdisciplinary innovation enables 10x faster enzyme engineering with a 200X higher chance of success compared to robotics which enables breakthrough development in a wide range of industries.
Phrixus Pharmaceuticals develops and commercializes heart failure-related pharmaceutical products and therapies.
OncoFusion Therapeutics is engaged in the R&D of personalized therapeutics for patients with genetically defined cancers.
At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine.
NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing
We create high-performing biobased ingredients and materials from sustainable processes at the best value for our customers.
MI Bioresearch is a contract research organization providing in vivo preclinical imaging services.
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with...
Arbor Assays specializes in the development of high sensitivity assay kits, high-purity inhibitors, and antibodies for drug discovery and basic research. Products for research in non-invasive endocrinology, mitochondrial dysfunction, oxidative stress, cell signaling biomarkers, kidney damage, cholinesterase activity, and other areas are readily available. We also offer custom assay development and testing services. We make unique kits to measure cGAMP,...
Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.
The Life Sciences business of Truven Health Analytics (www.truvenhealth.com/life-sciences) is a trusted, full service market access, stakeholder management, and health economics and outcomes research (HEOR) consultancy serving the global pharmaceutical, medical device and biotech industry. With the 2014 acquisition of Heartbeat Experts (www.heartbeatexperts.com) into our Life Sciences business, we offer the leading KOL and market access stakeholder identification, profiling, mapping...
ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.
Everist Health is a medicine company developing technologies focused on cancer, cardiovascular diseases and diabetes.
